Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide

References

• Allison SD. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv, 2008;5:615–28
   PubMed Web of Science ®Google Scholar
• Altman SA, Randers L, Rao G. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog, 1993;9:671–4
   PubMed Web of Science ®Google Scholar
• Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials, 1996;17:93–102
   PubMed Web of Science ®Google Scholar
• Bartsch W, Sponer G, Dietmann K, Fuchs G. Acute toxicity of various solvents in the mouse and rat. LD50 of ethanol, diethylacetamide, dimethylformamide, dimethylsulfoxide, glycerine, N-methylpyrrolidone, polyethylene glycol 400, 1,2-propanediol and Tween 20. Arzneimittelforschung, 1976;26:1581–3
   PubMed Web of Science ®Google Scholar
• Buske J, König C, Bassarab S, Lamprecht A, Mühlau S, Wagner KG. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. Eur J Pharm Biopharm, 2012;81:57–63
   PubMed Web of Science ®Google Scholar
• Camerini T, Mariani L, De Paolo G, Marubini E, Di Mauro MG, Decensi A, Costa A, Veronesi U. Safety of the synthetic retinoid fenretinide: Long-term results from a controlled clinical trial for the prevention of contralateral breast cancer. J Clin Oncol, 2001;19:1664–70
   PubMed Web of Science ®Google Scholar
• Carosio R, Pistoia V, Orienti I, Formelli F, Cavadini E, Mangraviti S, Montaldo PG, Ognio E, Emionite L, Zuccari G. Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration. J Pharm Pharmacol, 2012;64:228–36
   PubMed Web of Science ®Google Scholar
• Chaturvedi K, Kulkarni AR, Tejraj M, Aminabhavi TM. Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Indust Eng Chem Res, 2011;50:11797–807
   Google Scholar
• Clarke N, Germain P, Altucci L, Gronemeyer H. Retinoids: Potential in cancer prevention and therapy. Expert Rev Mol Med, 2004;6:1–23
   PubMedGoogle Scholar
• Corazzari M, Lovat PE, Oliviero S, Di Sano F, Donnorso RP, Redfern CP, Piacentini M. Fenretinide: A p53-independent way to kill cancer cells. Biochem Biophys Res Commun, 2005;331:810–5
   PubMed Web of Science ®Google Scholar
• Ganguly K, Aminabhavi TM, Kulkarni AR. Blend microspheres of poly(3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Indust Eng Chem Res, 2011;50:10414–23
   Google Scholar
• Garaventa A, Luksch R, Lo Piccolo MS, Cavadini E, Montaldo PG, Pizzitola MR, Boni L, Ponzoni M, Decensi A, De Bernardi B, et al. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res, 2003;9:2032–9
   PubMed Web of Science ®Google Scholar
• Hail N Jr, Kim HJ, Lotan R. Mechanisms of fenretinide-induced apoptosis. Apoptosis, 2006;11:1677–94
   PubMed Web of Science ®Google Scholar
• Hajiali H, Shahgasempour S, Naimi-Jamal MR, Peirovi H. Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering. Int J Nanomedicine, 2011;6:2133–41
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000;21:2475–90
   PubMed Web of Science ®Google Scholar
• Jiang WL, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev, 2005;57:391–410
   PubMed Web of Science ®Google Scholar
• Kenzaoui BH, Vilà MR, Miquel JM, Cengelli F, Juillerat-Jeanneret L. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomedicine, 2012;7:1275–86
   PubMed Web of Science ®Google Scholar
• Kuwahara K, Yang Z, Slack GC, Nimni ME, Han B. Cell delivery using an injectable and adhesive transglutaminase-gelatin gel. Tissue Eng Part C Methods, 2010;16:609–18
   PubMedGoogle Scholar
• Liu X, Heng WS, Paul, Li Q, Chan LW. Novel polymeric microspheres containing norcantharidin for chemoembolization. J Control Release, 2006;116:35–41
   PubMed Web of Science ®Google Scholar
• Lü JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn, 2009;9:325–41
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release, 2008;125:193–209
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB, Aminabhavi TM. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release, 2007;119:59–68
   PubMed Web of Science ®Google Scholar
• Orienti I, Zuccari G, Carosio R, Montaldo PG. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumour drugs by complexation with amphiphilic dextrins. Drug Deliv, 2009;16:389–98
   PubMed Web of Science ®Google Scholar
• Orienti I, Zuccari G, Falconi M, Teti G, Illingworth NA, Veal GJ. Novel micelles based on amphiphilic branched PEG as carriers for fenretinide. Nanomedicine, 2012;8:880–90
   PubMed Web of Science ®Google Scholar
• Owens DE III, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 2006;307:93–102
   PubMed Web of Science ®Google Scholar
• Patel P, Mundargi RC, Babu VR, Jain D, Rangaswamy V, Aminabhav TM. Microencapsulation of doxycycline into poly(lactide-co-glycolide) by spray drying technique: Effect of polymer molecular weight on process parameters. J Appl Polym Sci, 2008;108:4038–46
   Web of Science ®Google Scholar
• Sanghvi R, Narazaki R, Machatha SG, Yalkowsky SH. Solubility improvement of drugs using N-methyl pyrrolidone. AAPS PharmSciTech, 2008;9:366–76
   PubMed Web of Science ®Google Scholar
• Schwendeman SP. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit Rev Ther Drug Carrier Syst, 2002;19:73–98
   PubMed Web of Science ®Google Scholar
• Shelke NB, Rokhade AP, Aminabhavi TM. Preparation and evaluation of novel blend microspheres of poly(lactic-co-glycolic)acid and pluronic F68/127 for controlled release of repaglinide. J Appl Polym Sci, 2010;116:366–72
   Web of Science ®Google Scholar
• Sogno I, Venè R, Ferrari N, De Censi A, Imperatori A, Noonan DM, Tosetti F, Albini A. Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies. Crit Rev Oncol Hematol, 2010;75:2–14
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM. Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: Effect of process parameters and polymer type. J Microencapsul, 2002;19(3):281–92
   PubMedGoogle Scholar
• Veronesi U, Mariani L, Decensi A, Formelli F, Camerini T, Miceli R. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol, 2006;17:1065–71
   PubMed Web of Science ®Google Scholar
• Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP. Phase I trial of oral fenretinide in children with high-risk solid tumours: A report from the Children’s Oncology Group (CCG 09709). J Clin Oncol, 2006;24:3423–30
   PubMed Web of Science ®Google Scholar
• Wischke C, Zhang Y, Mittal S, Schwendeman SP. Development of PLGA-based injectable delivery systems for hydrophobic fenretinide. Pharm Res, 2010;27:2063–74
   PubMed Web of Science ®Google Scholar